Table 3.

Values for the Survival Curve on Figure 4

	Number at risk (months)
Bladder carcinoma
HR = 0.69
p = 0.021
	0	50	100	150
Low expression	115	16	3	2
High expression	289	50	9	1
Cervical
Cervical squamous cell carcinoma
HR = 0.53
p = 0.25
	0	50	100	150	200
Low expression	214	37	9	4	1
High expression	90	24	11	3	1
Stomach adenocarcinoma
HR = 0.66
p = 0.05
	0	20	40	60	80
Low expression	277	96	27	10	3
High expression	94	38	8	5	1
Kidney renal clear cell carcinoma
HR = 0.48
p = 1.6 × 10–6
	0	50	100	150
Low expression	159	46	6	0
High expression	371	160	34	1
Lung squamous cell carcinoma
HR = 0.68
p = 0.0087
	0	50	100	150
Low expression	309	52	16	2
High expression	186	53	11	3
Sarcoma
HR = 0.52
p = 0.0021
	0	50	100	150
Low expression	64	14	4	2
High expression	195	59	12	3
Kidney renal papillary cell carcinoma
HR = 1.73
p = 0.07
	0	50	100	150	200
Low expression	155	38	9	1	0
High expression	132	35	3	0	0
Liver hepatocellular carcinoma
HR = 1.48
p = 0.053
	0	20	40	60	80
Low expression	114	54	27	17	8
High expression	256	128	57	25	11
Pancreatic ductal adenocarcinoma
HR = 1.56
p = 0.45
	0	20	40	60	80
Low expression	127	46	15	8	1
High expression	50	12	2	0	0
Thymoma
HR = 4.27
p = 0.032
	0	50	100	150
Low expression	87	40	11	2
High expression	31	10	0	0
Thyroid carcinoma
HR = 1.93
p = 0.19
	0	50	100	150
Low expression	365	90	22	3
High expression	137	38	12	4
Uterine corpus endometrial carcinoma
HR = 1.37
p = 0.16
	0	50	100	150	200
Low expression	377	115	17	3	1
High expression	165	32	3	0	0

HR, hazard ratio.